Developing Responsible Neurotechnology for Chronic Pain
The UKRI Chronic Pain Neurotechnology Network+ is an EPSRC-funded UK community of researchers, clinicians and technologists dedicated to translational neurotechnology and innovation in the management of chronic pain. The network oversees a diverse range of activities to support research, training and collaboration.
Latest news
Free online webinar on ‘Learning How to Get Old: A Balance of Immunity and Autoimmunity’ by Prof. Eoin Mckinney, University of Cambridge
This talk explores groundbreaking research on immune ageing, analysing data from over 6,700 individuals to reveal how immune traits change across the lifespan. Using machine learning, Eoin’s work identifies "immune age" as a predictor of mortality, independent of chronological age, and highlights key immune mechanisms linked to survival. Genetic analyses further uncover connections between immune ageing and autoimmune diseases, offering new insights into ageing and longevity.
University of Oxford – Vice Chancellor guest edit on BBC Radio 4
The Vice Chancellor of the University of Oxford, Professor Irene Tracey’s guest edit was broadcast on 28 December 2024. The programme features our CPNN+ P.I (Professor Ben Seymour) who describes his own pain lab at Oxford. Professor Tracey, also a neuroscientist, reflects on her own research field in understanding and treating pain, and the broader role that Universities play in society.
‘Ouch! Solving the riddle of pain’
We all know what hurts, but why is it so difficult to describe? Emma Cook (Assistant Editor for The Observer magazine) meets the neurologists attempting to solve one of medicine’s most enduring issues and what it means for patients – and hears from a woman who has never felt pain.
CPNN+ Annual Report 2023-24
Our latest annual report is now available to view. Please visit our 'Publications' section from the main menu to download a copy.
PPI for Neurotech
Are you interested in PPI for Neurotech? Our network partners have recently published guidelines for public and patient involvement in neurotech. Please click on this news article or scroll below to find out more!